🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to compare the free time to disease progressio...
Status
Completed
Location
Spanish Cooperative Group for Gastrointestinal Tumour Therapy
Start Date
2006-07
Trial ID
NCT00335595
This study is being done to find out how effective a new treatment strategy...
Status
Completed
Location
Memorial Sloan Kettering Cancer Center
Start Date
2008-08
Trial ID
NCT00737438
Treatments Being Tested
The purpose of this study is to determinate progression free survival after...
Status
Completed
Location
Hospital 12 de Octubre
Start Date
2006-06
Trial ID
NCT00345696
Treatments Being Tested
The percentage of patients with defined unresectable metastatic disease who...
Status
Withdrawn
Location
The Ottawa Hospital Cancer Center
Start Date
2011-03
Trial ID
NCT01293942
Treatments Being Tested
Background: Colorectal cancer is a common cancer in the Unites States (U.S...
Status
Terminated
Location
Lombardi Comprehensive Cancer Center
Start Date
2017-04-05
Trial ID
NCT03050814
To evaluate the efficacy and safety of short-course radiotherapy followed b...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-06-30
Trial ID
NCT07059949
Treatments Being Tested
To evaluate the tolerability and safety of combination of ONO-4578 and ONO-...
Status
Active Not Recruiting
Location
National Cancer Center Hospital East
Start Date
2021-01-13
Trial ID
NCT06547385
Treatments Being Tested
The goal of this clinical research study is to find the highest tolerable d...
Status
Completed
Location
University of Texas MD Anderson Cancer Center
Start Date
2010-09-30
Trial ID
NCT01213238
Treatments Being Tested
This study is designed to evaluate the efficacy and safety of first-line tr...
Status
Completed
Location
Gemeinschaftspraxis für Hämatologie und Onkologie
Start Date
2018-05-24
Trial ID
NCT03462251
HS-20093 is a fully humanized IgG1 antibody-drug conjugate (ADC) which spec...
Status
Recruiting
Location
The Second Affiliated Hospital Zhejiang University
Start Date
2024-10-03
Trial ID
NCT06825624
Treatments Being Tested